Cargando…
Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
Treatment of elderly patients with neoplasia is challenging. Age is a known prognostic factor in ovarian cancer but the optimal treatment of elderly patients has not been determined. We undertook a retrospective analysis to determine clinical practice in advanced-stage ovarian cancer patients older...
Autores principales: | Liontos, Michalis, Papatheodoridi, Alkistis, Andrikopoulou, Angeliki, Thomakos, Nikolaos, Haidopoulos, Dimitrios, Rodolakis, Alexandros, Zagouri, Flora, Bamias, Aristotelis, Dimopoulos, Meletios-Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025751/ https://www.ncbi.nlm.nih.gov/pubmed/33800101 http://dx.doi.org/10.3390/curroncol28020110 |
Ejemplares similares
-
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
por: Andrikopoulou, Angeliki, et al.
Publicado: (2023) -
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
por: Liontos, Michalis, et al.
Publicado: (2021) -
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
por: Liontos, Michalis, et al.
Publicado: (2021) -
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility
por: Rodolakis, Ioannis, et al.
Publicado: (2023) -
Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
por: Kaparelou, Maria, et al.
Publicado: (2022)